Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have been given an average rating of “Moderate Buy” by the eleven ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation, seven have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $131.2222.
A number of research analysts have recently commented on the stock. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 21st. Citizens Jmp restated a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a report on Monday. Stephens dropped their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. Barclays dropped their target price on shares of Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating on the stock in a report on Friday. Finally, Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th.
Get Our Latest Research Report on Addus HomeCare
Addus HomeCare Trading Up 1.8%
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, topping analysts’ consensus estimates of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period in the prior year, the business posted $1.42 earnings per share. Equities research analysts forecast that Addus HomeCare will post 6.24 earnings per share for the current year.
Insider Activity at Addus HomeCare
In other Addus HomeCare news, EVP Brian Poff sold 2,041 shares of the stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $218,346.18. Following the transaction, the executive vice president directly owned 64,512 shares in the company, valued at $6,901,493.76. This represents a 3.07% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Darby Anderson sold 733 shares of the stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $106.98, for a total transaction of $78,416.34. Following the transaction, the executive vice president owned 46,642 shares in the company, valued at approximately $4,989,761.16. The trade was a 1.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 16,788 shares of company stock worth $1,785,633 over the last quarter. Corporate insiders own 4.50% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC grew its holdings in Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after buying an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC purchased a new stake in shares of Addus HomeCare during the fourth quarter valued at about $29,000. Private Trust Co. NA lifted its position in shares of Addus HomeCare by 65.5% during the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after buying an additional 112 shares during the last quarter. Finally, Arax Advisory Partners lifted its position in shares of Addus HomeCare by 95.8% during the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after buying an additional 137 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Read More
- Five stocks we like better than Addus HomeCare
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
